Abstract
BackgroundThe optimal number of neoadjuvant chemotherapy cycles in patients with advanced ovarian cancer is still disputed.ObjectiveTo evaluate the impact of the number of neoadjuvant chemotherapy cycles and role of optimal...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have